SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001113148-20-000040
Filing Date
2020-11-09
Accepted
2020-11-09 16:16:32
Documents
17
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K infi-20201109.htm   iXBRL 8-K 40769
2 EX-99.1 pressrelease2020q310q.htm EX-99.1 98793
3 EX-99.2 pressreleaseinfisitc20.htm EX-99.2 21921
9 GRAPHIC headera031.jpg GRAPHIC 24003
  Complete submission text file 0001113148-20-000040.txt   358302

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20201109.xsd EX-101.SCH 2411
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20201109_cal.xml EX-101.CAL 702
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20201109_def.xml EX-101.DEF 1635
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20201109_lab.xml EX-101.LAB 24993
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20201109_pre.xml EX-101.PRE 13182
10 EXTRACTED XBRL INSTANCE DOCUMENT infi-20201109_htm.xml XML 11513
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 201297893
SIC: 2834 Pharmaceutical Preparations